SCHEMBL7216291

SCHEMBL7216291

NS(=O)(=O)c1ccc(-c2cc(C(F)(F)F)cn2-c2ccc(F)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.62
PTGS1 P23219 9/20 0.62
CHRNA7 P36544 2/20 0.60
CYP2C9 P11712 1/20 0.55
CA12 O43570 2/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
PDPK1 O15530 2/20 0.54
KIF11 P52732 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1270876 1.00 PTGS2 (0.62) PTGS2PTGS1CHRNA7CYP2C9CA12
SCHEMBL1123595 0.86 KIF11 (0.51) PTGS2PTGS1CYP2C9CA12CA1
SCHEMBL7212037 0.85 PTGS2 (0.63) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7216202 0.84 PTGS2 (0.59) PTGS2PTGS1CHRNA7CYP2C9CA12
SCHEMBL2466828 0.83 CHRNA7 (0.66) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL5309196 0.83 CHRNA7 (0.66) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL1123613 0.83 PTGS2 (0.60) PTGS2PTGS1CHRNA7CYP2C9PDPK1
SCHEMBL1123783 0.83 PTGS2 (0.61) PTGS2PTGS1CYP2C9CA12CA1
SCHEMBL7210614 0.82 PTGS2 (0.63) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7216347 0.81 CHRNA7 (0.70) PTGS2PTGS1CHRNA7CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP disclosed
EP-0946507-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1999-10-06 EP disclosed
WO-1998025896-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-06-18 WO disclosed